Cardiovascular Anastomosis Devices Market Overview, Drivers And Restraints By 2030

Cardiovascular Anastomosis Devices Industry Overview

The global cardiovascular anastomosis devices market size was valued at USD 1.10 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.5% from 2022 to 2030.

Anastomotic devices are becoming popular as a safe and faster solution for saphenous aortic anastomosis. Medical technology companies are introducing innovative products in the market in line with the rising awareness and demand related to these devices. During the peak of the COVID-19 pandemic, only emergency cases such as acute aortic dissections were allowed to be treated, with patients being treated based on surgical priority while all elective procedures were canceled. In the U.S., there was around a 52% reduction in adult cardiac surgery volume, and almost a 65% reduction in elective cases, based on the database by the Society of Thoracic Surgeons Adult Cardiac Surgery.

Gather more insights about the market drivers, restrains and growth of the Global Cardiovascular Anastomosis Devices Market

U.S. cardiovascular anastomosis devices market size, by product type, 2020 - 2030 (USD Million)

Cardiac surgery patients have an increased risk of complications from COVID-19 and need vital resources including ICU beds, also required by COVID-19 patients. Therefore, hospital admissions for elective procedures were reduced to prevent potential hospital-acquired infections.

Effective long-term patency of the graft is crucial during any surgical coronary revascularization procedure. Graft patency and patient outcomes can be largely impacted by the quality of the anastomosis and inter- & intra-surgeon variability in the surgical techniques. Anastomotic devices can facilitate the creation of reproducible, rapid, and compliant anastomoses in potentially difficult-to-access areas, on- or off-pump, through minimal access incisions, with neuroprotective advantages.

The usage of anastomotic devices decreases the extent of aortic manipulation required for creating a graft based on aortic inflow. This allows surgeons to safely construct aortocoronary grafts. Anastomosis devices have paved the way for better outcomes in cardiovascular surgeries.

Off-pump coronary artery bypass (OPCAB) grafting is considered the gold standard for cardiac surgeries. It helps to decrease the incidences of postoperative complications caused by aortic intubation. It is most effective in minimally invasive surgeries and aids in avoiding multiple organ malfunctions caused by cardiopulmonary bypass.

Cardiovascular diseases are one of the leading causes of death across the globe. According to the WHO, cardiovascular diseases accounted for over 17.9 million deaths in 2019, accounting for 32% of all global deaths. According to CDC, 18.2 million adults have coronary artery diseases (CAD) in the U.S. CADs are the cause of around 20% of deaths in adults aged below 65 years. The rise in sedentary lifestyle, along with increasing smoking, tobacco, and alcohol consumption is expected to contribute to the number of cardiovascular surgeries in the coming years.

Browse through Grand View Research's Medical Devices Industry Research Reports.

  • Vascular Access Devices Market - The global vascular access devices market size was valued at USD 1.77 billion in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 5% from 2023 to 2030.
  • Medical Device Regulatory Affairs Market - The global medical device regulatory affairs market was valued at USD 5.6 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 10.1% from 2023 to 2030.

Market Share Insights

  • March 2019: Medtronic plc signed an agreement to acquire a medical device company, EPIX Therapeutics, Inc., that manufactures a catheter-based cardiac ablation system to treat cardiac arrhythmias. This acquisition expanded Medtronic’s cardiac ablation portfolio of a comprehensive suite of tools to treat cardiac arrhythmias.
  • November 2018: Peters Surgical invested around USD 5 million, after the acquisition of the Gurgaon-based Stericat, to further expand its existing manufacturing facility in India.

Key Companies profiled:

Some prominent players in the global cardiovascular anastomosis devices market include

  • Abbott 
  • Braun Melsungen AG
  • Getinge AB
  • Medtronic 
  • Peters Surgical

Order a free sample PDF of the Cardiovascular Anastomosis Devices Market Intelligence Study, published by Grand View Research.

Comments

Popular posts from this blog

South Africa Veterinary Medicine Market Size, Share, Revenue Analysis By 2028

U.S. Cold Storage Market Distributor Analysis and Forecasts By 2030

Fencing Market Competitive Landscape And Component Benchmarking 2030